Filter Results:
(1,601)
Show Results For
- All HBS Web
(4,939)
- Faculty Publications (1,601)
Show Results For
- All HBS Web
(4,939)
- Faculty Publications (1,601)
Controls
→
- 2023
- Book
Build the Life You Want: The Art and Science of Getting Happier
By: Arthur C. Brooks and Oprah Winfrey
In Build the Life You Want, Arthur C. Brooks and Oprah Winfrey invite you to begin a journey toward greater happiness no matter how challenging your circumstances. Drawing on cutting-edge science and their years of helping people translate ideas into action,... View Details
Brooks, Arthur C., and Oprah Winfrey. Build the Life You Want: The Art and Science of Getting Happier. Portfolio, 2023.
- 2023
- Working Paper
The Stock Market and Bank Risk-Taking
By: David S. Scharfstein and Antonio Falato
Using confidential supervisory risk ratings, we document that banks increase risk after they go public compared to a control group of banks that filed to go public but withdrew their filings for plausibly exogenous reasons. The increase in risk increases short-term... View Details
Scharfstein, David S., and Antonio Falato. "The Stock Market and Bank Risk-Taking." Working Paper, September 2023.
- August 2023
- Case
Floward
By: Krishna Palepu and Namrata Arora
In 2022, Abdulaziz B. Al Loughani, CEO and co-founder of Floward, an online flower and gifting company established in Kuwait in 2017, contemplated the firm's growth trajectory. Floward, an e-commerce enterprise that offered fresh-cut flowers sourced directly from... View Details
Keywords: Initial Public Offering; Expansion; Growth and Development Strategy; E-commerce; Information Technology Industry; Middle East; North Africa; Saudi Arabia; Kuwait; United Arab Emirates; Jordan
Palepu, Krishna, and Namrata Arora. "Floward." Harvard Business School Case 124-010, August 2023.
- August 2023 (Revised February 2024)
- Case
DexAI
By: Jo Tango and Christina Wallace
During a challenging fundraising environment, the DexAI founders received two term sheets with nearly identical economic terms but very different legal ones. The entrepreneurs had to navigate: representations and warranties (their personal guarantees that the company's... View Details
- August 2023 (Revised May 2024)
- Case
Dicerna Pharmaceuticals: Decision Making in Clinical Trial Design and Operations
By: Satish Tadikonda and Amanda McEwen
The success or failure of Dicerna Pharmaceuticals (Dicerna) as an emerging pharmaceutical company would likely hinge on its lead drug candidate Nedosiran and the company’s ability to see it successfully through clinical development. Ralf Rosskamp, Chief Medical... View Details
Keywords: Business Strategy; Health Testing and Trials; Product Development; Governing Rules, Regulations, and Reforms; Pharmaceutical Industry
Tadikonda, Satish, and Amanda McEwen. "Dicerna Pharmaceuticals: Decision Making in Clinical Trial Design and Operations." Harvard Business School Case 824-018, August 2023. (Revised May 2024.)
- July–August 2023
- Article
Demand Learning and Pricing for Varying Assortments
By: Kris Ferreira and Emily Mower
Problem Definition: We consider the problem of demand learning and pricing for retailers who offer assortments of substitutable products that change frequently, e.g., due to limited inventory, perishable or time-sensitive products, or the retailer’s desire to... View Details
Keywords: Experiments; Pricing And Revenue Management; Retailing; Demand Estimation; Pricing Algorithm; Marketing; Price; Demand and Consumers; Mathematical Methods
Ferreira, Kris, and Emily Mower. "Demand Learning and Pricing for Varying Assortments." Manufacturing & Service Operations Management 25, no. 4 (July–August 2023): 1227–1244. (Finalist, Practice-Based Research Competition, MSOM (2021) and Finalist, Revenue Management & Pricing Section Practice Award, INFORMS (2019).)
- 2023
- Working Paper
Much Ado About Nothing? Overreaction to Random Regulatory Audits
By: Samuel Antill and Joseph Kalmenovitz
Regulators often audit firms to detect non-compliance. Exploiting a natural experiment in the lobbying industry, we show that firms overreact to audits and this response distorts prices and reduces welfare. Each year, federal regulators audit a random sample of... View Details
Antill, Samuel, and Joseph Kalmenovitz. "Much Ado About Nothing? Overreaction to Random Regulatory Audits." Working Paper, August 2023.
- 2023
- Article
Towards Bridging the Gaps between the Right to Explanation and the Right to Be Forgotten
By: Himabindu Lakkaraju, Satyapriya Krishna and Jiaqi Ma
The Right to Explanation and the Right to be Forgotten are two important principles outlined to regulate algorithmic decision making and data usage in real-world applications. While the right to explanation allows individuals to request an actionable explanation for an... View Details
Keywords: Analytics and Data Science; AI and Machine Learning; Decision Making; Governing Rules, Regulations, and Reforms
Lakkaraju, Himabindu, Satyapriya Krishna, and Jiaqi Ma. "Towards Bridging the Gaps between the Right to Explanation and the Right to Be Forgotten." Proceedings of the International Conference on Machine Learning (ICML) 40th (2023): 17808–17826.
- 2023
- Working Paper
Beyond the Hype: Unveiling the Marginal Benefits of 3D Virtual Tours in Real Estate
By: Mengxia Zhang and Isamar Troncoso
3D virtual tours (VTs) have become a popular digital tool in real estate platforms, enabling potential buyers to virtually walk through the houses they search for online. In this paper, we study home sellers’ adoption of VTs and the VTs’ relative benefits compared to... View Details
Zhang, Mengxia, and Isamar Troncoso. "Beyond the Hype: Unveiling the Marginal Benefits of 3D Virtual Tours in Real Estate." Harvard Business School Working Paper, No. 24-003, July 2023.
- 2023
- Article
Evidence from the First Shared Medical Appointments (SMAs) Randomised Controlled Trial in India: SMAs Increase the Satisfaction, Knowledge, and Medication Compliance of Patients with Glaucoma
By: Nazlı Sönmez, Kavitha Srinivasan, Rengaraj Venkatesh, Ryan W. Buell and Kamalini Ramdas
In Shared Medical Appointments (SMAs), patients with similar conditions meet the physician together and each receives one-on-one attention. SMAs can improve outcomes and physician productivity. Yet privacy concerns have stymied adoption. In physician-deprived nations,... View Details
Sönmez, Nazlı, Kavitha Srinivasan, Rengaraj Venkatesh, Ryan W. Buell, and Kamalini Ramdas. "Evidence from the First Shared Medical Appointments (SMAs) Randomised Controlled Trial in India: SMAs Increase the Satisfaction, Knowledge, and Medication Compliance of Patients with Glaucoma." e0001648. PLoS Global Public Health 3, no. 7 (2023).
- July 13, 2023
- Article
Threads Foreshadows a Big—and Surprising—Shift in Social Media
By: Scott Duke Kominers and Liang Wu
Threads, Meta’s Twitter competitor, has become the fastest downloaded app in history. One of the reasons for this is because it allows users to port over their profiles and follows from the already popular social media platform Instagram, also owned by Meta—a feature... View Details
Keywords: Decentralization; Twitter; Facebook; Instagram; Crypto Economy; Blockchain; Network; Industrial Organization; Competition; Open Innovation; Open Platforms; Open Source Innovation; Social Networks; Social Media; Applications and Software; Information Technology Industry
Kominers, Scott Duke, and Liang Wu. "Threads Foreshadows a Big—and Surprising—Shift in Social Media." Harvard Business Review Digital Articles (July 13, 2023).
- July 2023
- Article
Managerial Quality and Productivity Dynamics
By: Achyuta Adhvaryu, Anant Nyshadham and Jorge Tamayo
Do productivity and managerial quality vary within the firm? If so which managerial traits and practices matter most for team productivity? Combining granular garment production data with survey data on managers across 120 production lines in India, we document... View Details
Keywords: Productivity; Non-cognitive Skills; Learning By Doing; Ready-made Garments; Management; Management Practices and Processes; Management Skills; Performance Productivity; Fashion Industry; Manufacturing Industry; India
Adhvaryu, Achyuta, Anant Nyshadham, and Jorge Tamayo. "Managerial Quality and Productivity Dynamics." Review of Economic Studies 90, no. 4 (July 2023): 1569–1607.
- July 2023
- Article
So, Who Likes You? Evidence from a Randomized Field Experiment
By: Ravi Bapna, Edward McFowland III, Probal Mojumder, Jui Ramaprasad and Akhmed Umyarov
With one-third of marriages in the United States beginning online, online dating platforms have become important curators of the modern social fabric. Prior work on online dating has elicited two critical frictions in the heterosexual dating market. Women, governed by... View Details
Keywords: Online Dating; Internet and the Web; Analytics and Data Science; Gender; Emotions; Social and Collaborative Networks
Bapna, Ravi, Edward McFowland III, Probal Mojumder, Jui Ramaprasad, and Akhmed Umyarov. "So, Who Likes You? Evidence from a Randomized Field Experiment." Management Science 69, no. 7 (July 2023): 3939–3957.
- 2023
- Book
The State and Capitalism in China
By: Meg Rithmire, Margaret M. Pearson and Kellee S. Tsai
This element explains China's political economic evolution from state socialist economy to a reform era state capitalism model to a more politicized, risk management approach we call "party-state capitalism." We emphasize the internal and external sources of perceived... View Details
Keywords: China's Political Economy; State Capitalism; State-business Relations; State Ownership; Economic Systems; Government and Politics; Governing Rules, Regulations, and Reforms; Business and Government Relations; China
Rithmire, Meg, Margaret M. Pearson, and Kellee S. Tsai. The State and Capitalism in China. Cambridge Elements, Elements in Politics and Society in East Asia. New York: Cambridge University Press, 2023.
- June 2023 (Revised July 2024)
- Case
Biogen and the Aduhelm Melee
By: Amitabh Chandra and Lauren Gunasti
Alzheimer's Disease is a devastating condition affecting millions of Americans. At this time, there is no cure. In 2021, Biogen's Aduhelm (aducanumab) received FDA approval under the accelerated approval pathway after a controversial approval process.
This... View Details
This... View Details
Keywords: Health Testing and Trials; Governing Rules, Regulations, and Reforms; Valuation; Product Development; Pharmaceutical Industry
Chandra, Amitabh, and Lauren Gunasti. "Biogen and the Aduhelm Melee." Harvard Business School Case 623-046, June 2023. (Revised July 2024.)
- June 2023
- Case
The Business of Campaigns
By: Vincent Pons and Mel Martin
In 2022, the U.S. Congress examined the Democracy Is Strengthened by Casting Light on Spending in Elections (DISCLOSE) Act, the latest in a long series of campaign finance reforms. According to its authors, the law would be the “most consequential overhaul of federal... View Details
Keywords: Political Elections; Government Legislation; Governing Rules, Regulations, and Reforms; Business and Government Relations; United States
Pons, Vincent, and Mel Martin. "The Business of Campaigns." Harvard Business School Case 723-039, June 2023.
- June 2023
- Case
Rent Control in Boston, Again?
By: Robin Greenwood, Richard S. Ruback, Robert Ialenti and Tom Quinn
This case explores the merits and drawbacks of Boston Mayor Michelle Wu’s proposal to bring rent control back to the city in 2023. It lays out the features, objectives, and potential unintended consequences of this policy, before highlighting the expected impact of... View Details
Greenwood, Robin, Richard S. Ruback, Robert Ialenti, and Tom Quinn. "Rent Control in Boston, Again?" Harvard Business School Case 223-083, June 2023.
- June 2023
- Article
Regulatory Limits to Risk Management
By: Ishita Sen
Variable annuities, the largest liability of U.S. life insurers, are investment products containing long-dated minimum return guarantees. I show that guarantees with similar economic risks are treated differently by regulation and these differences impact insurers’... View Details
Keywords: Interest Rate Risk; Variable Annuities; Capital Regulation; Reinsurance; Derivatives; Risk Management; Interest Rates; Governing Rules, Regulations, and Reforms
Sen, Ishita. "Regulatory Limits to Risk Management." Review of Financial Studies 36, no. 6 (June 2023): 2175–2223. (Lead Article and Editor's Choice, Winner of the RFS Rising Scholar Award 2024.)
- May 2023 (Revised November 2023)
- Case
Arcos Dorados: Decarbonizing McDonald's in Latin America
By: George Serafeim, Michael W. Toffel, Jenyfeer Martinez Buitrago and Mariana Cal
This case describes the decarbonization strategy of Arcos Dorados—McDonald’s largest independent franchisee, operating in 20 countries and territories in Latin America and the Caribbean—and how the company measured its greenhouse gas (GHG) emissions, including those... View Details
Keywords: Environmental Accounting; Animal-Based Agribusiness; Plant-Based Agribusiness; Change Management; Forecasting and Prediction; Environmental Sustainability; Food; Growth Management; Supply Chain; Corporate Social Responsibility and Impact; Strategy; Agriculture and Agribusiness Industry; Food and Beverage Industry; Green Technology Industry; Consumer Products Industry; Latin America; North and Central America; South America
Serafeim, George, Michael W. Toffel, Jenyfeer Martinez Buitrago, and Mariana Cal. "Arcos Dorados: Decarbonizing McDonald's in Latin America." Harvard Business School Case 623-017, May 2023. (Revised November 2023.)
- May–June 2023
- Article
A New Approach to Building Your Personal Brand: How to Communicate Your Value
By: Jill Avery and Rachel Greenwald
For better or worse, in today’s world everyone is a brand. Whether you’re applying for a job, asking for a promotion, or writing a dating profile, your success will depend on getting others to recognize your value. So you need to get comfortable marketing... View Details
Keywords: Personal Brand; Influencer Marketing; Leadership Development; Marketing; Brands and Branding; Identity; Reputation; Competency and Skills
Avery, Jill, and Rachel Greenwald. "A New Approach to Building Your Personal Brand: How to Communicate Your Value." Harvard Business Review 101, no. 3 (May–June 2023): 147–151.